[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-369331-105":59,"doc-detail-369331-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ncbp2-predicts-the-prognosis-and-the-immunotherapy-response-of-cancers-a-pan-cancer-analysis","NCBP2 predicts the prognosis and the immunotherapy response of cancers - a pan-cancer analysis","","Background. The cap-binding complex (CBC) is essential for gene expression by protecting mRNA from nonsense-mediated decay, supporting splicing, 3'-end processing, and nuclear export, yet CBC-related clinical roles in cancer remain unclear. Methods. The study used cBioPortal, TCGA, and web tools to assess NCBP2 genetic alterations and associations with prognosis, genomic instability, immune infiltration, immune response, stemness, and chemotherapy response; expression was validated with IHC and single-cell functions were explored using CancerSEA. Results. NCBP2 showed distinct pan-cancer expression patterns and survival correlations, with pathway links to immunity and proliferation, immune-score relationships, and drug sensitivity signals. Conclusion. NCBP2 may serve as a therapeutic target for more effective personalized cancer treatment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ncbp2-predicts-the-prognosis-and-the-immunotherapy-response-of-cancers-a-pan-cancer-analysis/369331/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ncbp2-predicts-the-prognosis-and-the-immunotherapy-response-of-cancers-a-pan-cancer-analysis/369331.png","ImageObject",300,407,{"name":92,"@type":93},"River Wang","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the study focusing on regarding NCBP2 in cancers?","Question",{"text":112,"@type":113},"The study investigates how nuclear cap binding protein subunit 2 (NCBP2) relates to cancer prognosis and immunotherapy response across multiple cancer types using pan-cancer analyses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were genetic alterations and prognostic associations analyzed?",{"text":117,"@type":113},"Genetic alterations were examined using cBioPortal, and TCGA plus online web tools were used to evaluate correlations between NCBP2 and outcomes such as overall survival, disease-specific survival, and progression-free survival, along with genomic instability and immune features.",{"name":119,"@type":110,"acceptedAnswer":120},"What key biological pathways and immune-related findings were reported?",{"text":121,"@type":113},"Gene Set Enrichment Analysis indicated that higher NCBP2 is linked to immune- and proliferation-related pathways, with observed relationships between NCBP2 and immune/stromal microenvironment scores and immune cell populations, as well as stemness-related indices.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},369331,1790644724,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","Submitted 16 September 2024 Accepted 4 February 2025  \nPublished 20 March 2025  \nCorresponding authors Shichao Li, [lishichao1208@126.com](lishichao1208@126.com)[ ](lishichao1208@126.com)Junyu Liu, [ljysci@foxmail.com](ljysci@foxmail.com)  \nAcademic editor Vladimir Uversky  \nAdditional Information and Declarations can be found on page 19  \nDOI 10.7717/peerj.19050  \n Copyright 2025 Li et al.  \nDistributed under  \nCreative Commons CC-BY 4.0  \nOPEN ACCESS  \nNCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis  \nShichao Li1 ,* , Yulan Wang1 ,* , Xi Yang2 , Miao Li3 , Guoxiang Li2 , Qiangqiang Song1 and Junyu Liu4  \n1 Department of Pathology, General Hospital of Xinjiang Military Command, Urumqi, Xinjiang, China  \n2 Department of Medical Service, General Hospital of Xinjiang Military Command, Urumqi, Xinjiang, China  \n3 School of Rehabilitation Medicine, Xinjiang Medical University, Urumqi, Xinjiang, China  \n4 Department of Gastroenterology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong, China  \n* These authors contributed equally to this work.  \nABSTRACT  \nBackground. The cap-binding complex (CBC) plays a crucial role in facilitating gene expression by safeguarding mRNA from nonsense-mediated decay, promoting mRNA splicing, 30-end processing, and facilitating nuclear export. Nevertheless, the precise biological functions and clinical implications of CBC in cancer remain ambiguous, necessitating further investigation for clarification.  \nMethods. The present study utilized the cBioPortal database to investigate the genetic alterations of nuclear cap binding protein subunit 2 (NCBP2) in pan-cancer. The Cancer Genome Atlas (TCGA) and online web tools were employed to analyze the correlation between NCBP2 and prognosis, genome instability, immune infiltration, immune response, cancer stemness, and chemotherapeutic efficacy in pan-cancer. Furthermore, the expression of NCBP2 was confirmed by immunohistochemistry (IHC) and functional analysis at the single-cell level was conducted using the CancerSEA database.  \nResults. NCBP2 exhibited distinct genetic alterations in pan-cancer with an increased expression in 24/32, while decreased expression in 3/32, types of cancers. IHC confirmed the aberrant expression of NCBP2 in lung squamous cell carcinoma (LUSC), pancreatic adenocarcinoma (PAAD), kidney renal papillary cell carcinoma (KIRP) and kidney renal clear cell carcinoma (KIRC) . NCBP2 was correlated with overall survival (OS), disease-specific survival (DSS), and progression-free survival (PFS) in various cancers. Importantly, it was identified as a risk factor for OS, DSS and PFS in PAAD and uterine corpus endometrial carcinoma (UCEC). Gene Set Enrichment Analysis (GSEA) demonstrated that elevated NCBP2 was linked to immune and proliferation related pathways across multiple cancer types. Furthermore, a negative association between NCBP2 and stromal score, immune score, and ESTIMATE score was detected, and a positive correlation was observed between NCBP2 and diverse immune cells as well as stemness-indexes in the majority of cancer types. Drug sensitivity analysis revealed that drugs associated with NCBP2 primarily targeted DNA replication, chromatin histone methylation, ABL signaling, cell cycle, and PI3K signaling. Additionally, an examination at the single-cell level indicated that NCBP2 was positively correlated with cell cycle progression, DNA damage, DNA repair, invasion, and stemness inmost cancer  \nHow to cite this article Li S, Wang Y, Yang X, Li M, Li G, Song Q, Liu J. 2025. NCBP2 predicts the prognosis and the immunotherapy response of cancers: a pan-cancer analysis. PeerJ 13:e19050 [http://doi.org/10.7717/peerj.19050](http://doi.org/10.7717/peerj.19050)  \ntypes, while negatively correlated with apoptosis, inflammation, and hypoxia in certain cancers.  \nConclusion. In this study, we revealed the correlation of NCBP2 with prognosis, microenvironment and ","cbCaijBShnSSn3ue","https://ap.wps.com/l/cbCaijBShnSSn3ue","pdf",23141562,26,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the study focusing on regarding NCBP2 in cancers?\",\"answer\":\"The study investigates how nuclear cap binding protein subunit 2 (NCBP2) relates to cancer prognosis and immunotherapy response across multiple cancer types using pan-cancer analyses.\"},{\"question\":\"How were genetic alterations and prognostic associations analyzed?\",\"answer\":\"Genetic alterations were examined using cBioPortal, and TCGA plus online web tools were used to evaluate correlations between NCBP2 and outcomes such as overall survival, disease-specific survival, and progression-free survival, along with genomic instability and immune features.\"},{\"question\":\"What key biological pathways and immune-related findings were reported?\",\"answer\":\"Gene Set Enrichment Analysis indicated that higher NCBP2 is linked to immune- and proliferation-related pathways, with observed relationships between NCBP2 and immune/stromal microenvironment scores and immune cell populations, as well as stemness-related indices.\"}]","NCBP2 predicts the prognosis and the immunotherapy response of cancers - a pan-cancer analysis | PDF",1790182087,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88ef34887fb40efc9e308abdf598d42a.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e2791c11a36bd8d20e875e616c0f348d.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99c28312476e41530eb5844e406f7529.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f25d402ec79d944400ba98af5a254cdc.webp",980,1268]